What is the ROCE (Return on Capital Employed) of Ibio this year?
The ROCE of Ibio is -1.87 undefined this year.
Ibio ROCE 2024
Ibio ROCE
-1.87
Ticker
IBIO
ISIN
US4510332038
WKN
A2JNBU
In 2024, Ibio's return on capital employed (ROCE) was -1.87, a 324.59% increase from the -0.44 ROCE in the previous year.
Ibio Aktienanalyse
What does Ibio do?
Ibio Inc is a US biopharmaceutical company founded in 2008. It is headquartered in Bryan, Texas and employs approximately 130 employees. The company is listed on the New York Stock Exchange (NYSE: IBIO). The business model of Ibio Inc is to develop innovative biopharmaceutical products and sell them in the market. The company utilizes plant expression systems technology to extract proteins and antibodies from plant cells, which significantly reduces production costs, allowing for cost-efficient manufacturing of rare and expensive medications. The company is divided into various divisions, including research and development, manufacturing of biopharmaceuticals, and vaccine production. In the research and development field, Ibio Inc focuses on innovative products in oncology and infectious diseases. One example of their products is IBIO-100, which is intended for the treatment of breast and prostate cancer. Another product of Ibio Inc is IBIO-CFB03, a vaccine against COVID-19 produced using plant expression technology. In 2020, the company formed a partnership with the Brazilian biotech company CC-Pharming Ltda. for this vaccine. Additionally, Ibio Inc is involved in the production of biopharmaceuticals, including various antibodies used in the treatment of cancer. One example is IBIO-101, a monoclonal antibody against the tumor protein folate receptor alpha, which can be used in the therapy of ovarian, breast, and lung cancer. The company collaborates closely with various partners in the pharmaceutical industry to bring its products to the market. This includes working with CC-Pharming, with whom they developed the COVID-19 vaccine, as well as Chinese biotech company CC-Pharming Shanghai Co. Ltd., which serves as a production partner for Ibio Inc. Ibio Inc is an innovative company that enables cost-efficient production of biopharmaceuticals through the use of plant expression technology. The company primarily focuses on oncology and infectious diseases and collaborates with partners in the pharmaceutical industry to bring its products to the market. Ibio ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Ibio's Return on Capital Employed (ROCE)
Ibio's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Ibio's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Ibio's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Ibio’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Ibio stock
How has the ROCE (Return on Capital Employed) of Ibio developed compared to the previous year?
The ROCE of Ibio has increased by 324.59% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Ibio?
A high Return on Capital Employed (ROCE) indicates that Ibio has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Ibio?
A low ROCE (Return on Capital Employed) can indicate that Ibio has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Ibio impact the company?
An increase in the ROCE of Ibio can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Ibio affect the company?
A decrease in ROCE of Ibio can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Ibio?
Some factors that can affect Ibio's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Ibio so important for investors?
The ROCE of Ibio is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Ibio take to improve the ROCE?
To improve the ROCE, Ibio can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Ibio pay?
Over the past 12 months, Ibio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ibio is expected to pay a dividend of 0 USD.
What is the dividend yield of Ibio?
The current dividend yield of Ibio is .
When does Ibio pay dividends?
Ibio pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Ibio?
Ibio paid dividends every year for the past 0 years.
What is the dividend of Ibio?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Ibio located?
Ibio is assigned to the 'Health' sector.
Wann musste ich die Aktien von Ibio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ibio from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.
When did Ibio pay the last dividend?
The last dividend was paid out on 9/19/2024.
What was the dividend of Ibio in the year 2023?
In the year 2023, Ibio distributed 0 USD as dividends.
In which currency does Ibio pay out the dividend?
The dividends of Ibio are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Ibio
Our stock analysis for Ibio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ibio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
